Target Name: ARMC9
NCBI ID: G80210
Review Report on ARMC9 Target / Biomarker Content of Review Report on ARMC9 Target / Biomarker
ARMC9
Other Name(s): KU-MEL-1 | JBTS30 | Melanoma/melanocyte specific protein KU-MEL-1 | armadillo repeat-containing protein 9 | ARMC9_HUMAN | Armadillo/beta-catenin-like repeats | KIAA1868 | armadillo repeat containing 9 | NS21 | Armadillo repeat-containing protein 9 | Melanoma/melanocyte-specific tumor antigen KU-MEL-1 | melanoma/melanocyte specific protein KU-MEL-1 | armadillo/beta-catenin-like repeats | melanoma/melanocyte-specific tumor antigen KU-MEL-1 | LisH domain-containing protein ARMC9 | OTTHUMP00000164302 | Armadillo repeat containing 9 | ARM | FLJ12584

ARMC9: A Potential Drug Target for Immune, Inflammation and Cellular Processes

ARMC9 (short for ARM-Chaperone-9) is a protein that is expressed in various cell types of the human body, including neurons, macrophages, and dendritic cells. It is a member of the ARH family of proteins, which are known for their role in intracellular signaling.

One of the key functions of ARMC9 is its role in cell signaling. It is a chaperone protein that helps to transport and present various signaling molecules to the cell surface, where they can interact with their targets and trigger signaling pathways. ARMC9 is also involved in the regulation of cellular processes such as cell adhesion, migration and invasion.

Another function of ARMC9 is its role in the regulation of inflammation. It is involved in the regulation of the immune response and has been shown to play a key role in the regulation of inflammatory responses.

ARMC9 has also been shown to be involved in the regulation of cell cycle progression. It helps to control the entry of new ```>``` cells into the cell cycle and also helps to maintain the stability of the cell cycle.

As a drug target, ARMC9 is an attractive target for researchers because of its various functions and its involvement in several different cellular processes. It is also a good candidate for a potential therapeutic intervention.

One of the potential benefits of targeting ARMC9 is its potential to treat several different diseases and conditions. For example, ARMC9 has been shown to be involved in the regulation of the immune response, which makes it a potential target for diseases that are characterized by an imbalance in the immune response. This includes diseases such as cancer, autoimmune diseases and chronic obstructive pulmonary disease (COPD).

Another potential benefit of targeting ARMC9 is its potential to treat memory loss and cognitive decline. ARMC9 has been shown to be involved in the regulation of the immune response and has been implicated in the development of memory loss and cognitive decline.

Additionally, ARMC9 has also been shown to be involved in the regulation of the blood-brain barrier, which is a barrier that separates the brain from the bloodstream. This suggests that ARMC9 may also be involved in the regulation of intracranial signaling, which could be a potential target for treating neurological diseases.

In addition to its potential therapeutic applications, ARMC9 also has several potential technical applications. For example, it can be used as a biomarker to diagnose and monitor certain diseases. It can also be used to track the delivery of drugs to specific cells in the body, which could be useful for targeting drugs to specific areas of the body.

Overall, ARMC9 is a protein that has a wide range of functions and its potential as a drug target. Further research is needed to fully understand its role in cellular processes and its potential as a therapeutic intervention.

Protein Name: Armadillo Repeat Containing 9

Functions: Involved in ciliogenesis (PubMed:32453716). It is required for appropriate acetylation and polyglutamylation of ciliary microtubules, and regulation of cilium length (PubMed:32453716). Acts as a positive regulator of hedgehog (Hh)signaling (By similarity). May participate in the trafficking and/or retention of GLI2 and GLI3 proteins at the ciliary tip (By similarity)

The "ARMC9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARMC9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ARMCX1 | ARMCX2 | ARMCX3 | ARMCX4 | ARMCX5 | ARMCX5-GPRASP2 | ARMCX6 | ARMCX7P | ARMH1 | ARMH2 | ARMH3 | ARMH4 | ARMS2 | ARMT1 | ARNT | ARNT2 | ARNT2-DT | ARPC1A | ARPC1B | ARPC2 | ARPC3 | ARPC3P2 | ARPC3P5 | ARPC4 | ARPC4-TTLL3 | ARPC5 | ARPC5L | ARPIN | ARPIN-AP3S2 | ARPP19 | ARPP21 | ARR3 | ARRB1 | ARRB2 | ARRDC1 | ARRDC1-AS1 | ARRDC2 | ARRDC3 | ARRDC3-AS1 | ARRDC4 | ARRDC5 | Arrestin | ARSA | ARSB | ARSD | ARSF | ARSG | ARSH | ARSI | ARSJ | ARSK | ARSL | ART1 | ART3 | ART4 | ART5 | ARTN | ARV1 | ARVCF | ARX | Arylsulfatase | AS3MT | ASAH1 | ASAH1-AS1 | ASAH2 | ASAH2B | ASAP1 | ASAP1-IT1 | ASAP1-IT2 | ASAP2 | ASAP3 | ASB1 | ASB10 | ASB11 | ASB12 | ASB13 | ASB14 | ASB15 | ASB16 | ASB16-AS1 | ASB17 | ASB18 | ASB2 | ASB3 | ASB4 | ASB5 | ASB6 | ASB7 | ASB8 | ASB9 | ASB9P1 | ASCC1 | ASCC2 | ASCC3 | ASCL1 | ASCL3 | ASCL4 | ASCL5 | ASF1A | ASF1B